MedPath
TGA Approval

PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle (447744)

447744

PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle

Boucher & Muir Pty Ltd

July 4, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

pazopanib hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.